Nearly a third of families with children receiving chemotherapy for acute lymphoblastic leukemia (ALL) – the most common pediatric cancer – develop serious financial difficulties during their child’s treatment, including losing 25% or more of their household income and struggling to cover the costs of basic living expenses such as housing, food, and utilities. Read more: https://www.eurekalert.org/news-releases/1108761

A new type of cancer cell that “warrants urgent investigation” has been discovered in childhood leukaemia and could impact clinical care. Research into new or repurposed treatments that target this new cell type could give hope to children and families worldwide. Read more: https://www.eurekalert.org/news-releases/1105676

A new study led by researchers at the University of Minnesota Medical School has identified genetic factors that may help explain why African American children are less likely to develop acute lymphoblastic leukemia (ALL) but tend to face worse outcomes when they do. Read more: https://twin-cities.umn.edu/news-events/university-minnesota-study-uncovers-new-genetic-factors-childhood-leukemia

The new paper reveals for the first time that these DNA fragments can persist in cancer cells and may drive relapse in patients with...

Chemotherapy resistance is particularly common in what is known as T-ALL, a subtype of ALL. This recent study shows that the origin of...

As we age, some populations of immune cells change in abundance and these changes can be measured and used to infer one’s immunological...

Planned caesarean births—"C-sections"—slightly raise the risk of some childhood cancers—particularly acute lymphoblastic leukemia (ALL),...

Scientists at St. Jude Children’s Research Hospital and University Health Network showed that the stage of B-cell development at which...

Investigators have discovered how NUP98-fusion proteins drive pediatric acute myeloid leukemia, identifying novel single-agent and...

A combination of two drugs could improve outcomes and reduce the need for toxic chemotherapy for B-cell acute lymphoblastic leukaemia...